The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 

 

This Article
-Full Text
NEJM -- Gearhart J, Pashos EE, Prasad MK. Pluripotency Redux -- Advances in Stem-Cell Research. 357(15):1469-72. Supplementary Audio

Interview with Douglas Melton on the promise and limitations of recent advances in stem-cell research

photo of Douglas Melton
 

Supplement to: Gearhart J, Pashos EE, Prasad MK. Pluripotency Redux — Advances in Stem-Cell Research. N Engl J Med 2007;357(15):1469-72.

Dr. Douglas Melton is scientific director of the Harvard Stem Cell Institute and a professor in the Department of Molecular and Cellular Biology at Harvard University.

Rachel Gotbaum, the interviewer, is an independent producer based in Boston.


HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.